Advanced prostate MRI to reduce unnecessary biopsies
Part of Cancer, Kidney & urinary clinical trials.
This study looks at using advanced MRI techniques to better spot prostate cancer, aiming to reduce unnecessary biopsies. It has two parts: one calibrates MRI scanners across hospitals, the other tests the new method in patients with suspicious MRI findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be able to have an MRI (no metal implants, claustrophobia, or other reasons that make MRI unsafe).
- You must be willing and able to give written consent to join.
- For the validation part: you must have a suspicious area on a prostate MRI (score 4 or 5) and be either watching a low-risk cancer or waiting for treatment. You also have to be able to get MRI scans at more than one hospital.
- For the calibration part: you must be having a prostate MRI and be able to travel to a partner hospital for extra scans.
- You must not have had a prostate biopsy in the last 3 months, and (for the validation part) you must not have had prior prostate cancer diagnosis or treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
This trial uses repeated MRI scans to monitor prostate lesions that have a low chance of being aggressive cancer. It is for people who have suspicious spots but whose initial biopsies did not find high-grade cancer.
This study tests a new computer program that reads prostate MRI images to help doctors diagnose prostate cancer more accurately. It may help you by providing a clearer picture of your condition without extra tests.
This study tests a new computer program that reads MRI scans to help doctors decide if a prostate biopsy is truly needed. It aims to reduce unnecessary biopsies for men with suspicious test results.
This trial tests if using MRI and a blood test called PHI can help decide who needs a prostate biopsy. It aims to avoid unnecessary biopsies while still catching cancer early.
This study checks whether a faster prostate MRI and image-matching (image-fusion) can better find suspicious spots so doctors can target a biopsy. If you have concerning prostate exam results or PSA blood test results, you may get an MRI and, if something looks suspicious, a biopsy using MRI images.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.